Johnson & Johnson vs Molina Healthcare Inc — Stock Comparison
Johnson & Johnson (JNJ) and Molina Healthcare Inc (MOH) are both listed on US exchanges. This page compares their Q·Score ratings, key fundamentals (P/E, margins, growth), and Wall Street analyst consensus side by side. Data sourced from Yahoo Finance and updated on each page load.
Johnson & Johnson clearly outscores Molina Healthcare Inc on Q·Score (7 vs 4.8 out of 10), led by Quality (9.3 vs 4.6) and Growth (5.1 vs 1.7). Molina Healthcare Inc scores higher on Valuation, reflecting stronger P/E and price-target positioning. Analyst consensus targets imply greater upside for JNJ (+9.1%) than for MOH (+5.4%).
Price Performance
Normalised to 100 at period start — shows relative performance.
Q·Score Breakdown
High-quality business with 26% return on equity and 22% profit margins.
⚠ earnings contracting 53% year-over-year.
Valuation metrics in line with sector peers.
⚠ revenue declining 4% year-over-year.
Analyst Consensus
Fundamentals
Frequently Asked Questions
JNJ vs MOH: which stock scores better overall?
Based on Q·Score, Johnson & Johnson (JNJ) scores 7/10 versus Molina Healthcare Inc (MOH) at 4.8/10. The Q·Score measures five dimensions: Quality, Health, Growth, Valuation, and Sentiment. For informational purposes only — not financial advice.
Which has better revenue growth: JNJ or MOH?
Johnson & Johnson (JNJ) scores higher on Growth (5.1/10 vs 1.7/10). Johnson & Johnson reports revenue growth (9.9% YoY) while Molina Healthcare Inc reports (-4.3% YoY). Growth scores reflect revenue and earnings momentum relative to sector peers.
Is JNJ or MOH more attractively valued?
Molina Healthcare Inc (MOH) scores higher on Valuation (7.7/10 vs 7/10). JNJ trades at 18.2× P/E versus MOH at 19.3×. Valuation is assessed using P/E ratio, analyst price targets, and 52-week range positioning relative to sector peers.
What do analysts say about JNJ vs MOH?
There are 24 analysts covering JNJ with a consensus price target of $252.96, and 16 analysts covering MOH with a consensus target of $186.63. Analyst consensus ratings are aggregated from Wall Street research and do not constitute investment advice.
Which is more profitable: JNJ or MOH?
Johnson & Johnson (JNJ) scores higher on Quality (9.3/10 vs 4.6/10). Net profit margin: JNJ at 21.8%, MOH at 0.4%. Quality scores reflect profit margins, return on equity, and free cash flow generation.
Which has stronger financial health: JNJ or MOH?
Johnson & Johnson (JNJ) scores higher on Financial Health (6.5/10 vs 6.1/10). Market beta: JNJ at 0.26, MOH at 0.85. Health scores consider beta, debt-to-equity, and current ratio. All investments carry risk — this is not investment advice.
What are the market caps of JNJ and MOH?
Johnson & Johnson (JNJ) has a market capitalisation of $558.0B, while Molina Healthcare Inc (MOH) has a market cap of $9.2B. Market cap data is sourced from Yahoo Finance and reflects the most recent available figures.
Do JNJ or MOH pay dividends?
JNJ pays a dividend yield of 2.32%, while MOH does not currently pay a dividend. Dividend yields fluctuate with share price and company payout decisions.
Related Comparisons
Q·Score is an educational tool and is not financial advice. Data provided by Yahoo Finance. Updated on each page load. How it's calculated →